These encouraging findings, together with the growing availability of clinically relevant NF1 and MPNST models, suggest that oHSV-based therapies hold strong potential for future MPNST treatment and clinical translation [116]. Here, NF1 is linked to malignant peripheral nerve sheath tumor.